Prognostic Factors for Patients with Bone Metastasis from Lung Cancer

Shun TANG,Wei GUO,Rongli YANG

DOI: https://doi.org/10.3969/j.issn.1000-8179.2008.23.005

2008-01-01

Chinese Journal of Clinical Oncology

Abstract:Objective: Lung cancer is one of the most common solid tumors that metastasizes to bone. The aim of this study was to assess prognostic factors of patients with bone metastasis from lung cancer. Methods: We followed up 127 patients with bone metastases from lung cancer seen in our hospital during October 1997 and January 2007. There were 84 males and 43 females with an average age of 61.2 years. Plain radiographs, CT, MRI and bone scintigraphy were used for detection of bone metastases. Based on pathologic study, tumors were histologically identified as adenocarcinoma in 80 patients (63.0%), squamous cell carcinoma in 17 patients (13.4%), large cell carcinoma in 9 patients (7.1%), and small cell carcinoma in 21 patients (16.5%). We used Kaplan-Meier survival curve and Cox comparative hazards model to analyze prognostic factors. Several predictors of survival have been identified. Results: The 6-month and 1- and 2-year cumulative survival rates after bone metastasis from lung cancer were 72.4%, 25.8%, and 8%, respectively. The median survival time of these patients was 10.6 months, and the median survival time after the diagnosis of bone metastasis was 6.7 months. Univariate analysis showed that the significant prognostic factors for survival of lung cancer patients with bone metastasis included patients'survival state, tumor subtype, the number of metastatic foci, bone destruction, visceral metastases, the interval between the diagnosis of lung cancer and bone metastasis, presence of skeletal complications (pathologic fracture or spinal cord compression). Multivariate analysis showed that the significant prognostic factors included patients'survival state, tumor subtype, the number of metastasis foci (isolated or multiple), visceral metastases, and interval between the diagnosis of lung cancer and bone metastasis. Conclusion: The prognostic factors for survival are useful for determining the optimal surgical method, and they are valuable for improving the survival of lung cancer patients with bone metastases.